AGORA Cancer Research Center

AGORA was inspired by the vision that the integration of progress in cancer research into clinical practice can be accelerated by bringing together interdisciplinary research teams of clinicians, cancer biologists, immunologists, bio-informaticians and bio-engineers. Initiated by the ISREC Foundation in 2013, the AGORA building was opened in 2018. The functioning of this translational cancer research center reflects a partnership between the Lausanne University Hospital (CHUV), the University of Lausanne (UNIL), the Swiss Federal Institute of Technology of Lausanne (EPFL), the University Hospitals of Geneva (HUG) and the University of Geneva (UNIGE).

Latest news

Events

PhD Thesis Defense | April 25th

More information

Events

AGORA PRS Seminar | April 29th

More information

Events

Oncology Grand Rounds, Dr. Julien Flückiger | May 2nd

More information

Events

Lausanne Proteomics Day 2025 | May 7th

Register

News

Prof. Olivier Michielin Receives 2025 Leenaards Scientific Award for Cancer Research

Events

AGORA Tumor Microenvironment Journal Club

More information

Events

FameLab Event in Lausanne | May 28

More information

News

Prof. Mikaël Pittet discusses ketogenic diet and CAR-T cells in RTS podcast

Events

ISREC-SCCL Symposium 2025 | September 1–4

Register

Highlight

Prof. Douglas Hanahan Receives Pezcoller-AACR Award

Highlighted publication

The local microenvironment suppresses the synergy between irradiation and anti-PD1 therapy in breast-to-brain metastasis.

Wischnewski V, Guerrero Aruffo P, Massara M, (…), Maas RR, Soukup K, Joyce JA

Cell reports – 2025 Mar 25

Highlighted publication

Bevacizumab, atezolizumab and acetylsalicylic acid in recurrent, platinum-resistant ovarian cancer: the EORTC 1508-GCG phase II study.

Banerjee S, Ghisoni E, Wolfer A, (…), Coens C, Dangaj Laniti D, Coukos G

Clinical cancer research – 2025 Mar 18

Past news

Latest publications

Reprogramming the tumor immune microenvironment to treat glioblastoma.

Joyce JA

Nature Medicine – 2025 Apr 15

Safety of adoptive therapy with tumor-infiltrating lymphocytes and high-dose recombinant interleukin-2 in advanced cutaneous melanoma: a systematic review and meta-analysis.

Martín-Lluesma S, Dafni U, Vervita K, (…), Gros A, Coukos G, Garralda E

Annals of oncology – 2025 Apr 8

The local microenvironment suppresses the synergy between irradiation and anti-PD1 therapy in breast-to-brain metastasis.

Wischnewski V, Guerrero Aruffo P, Massara M, (…), Maas RR, Soukup K, Joyce JA

Cell reports – 2025 Mar 25

Enrichment of CD7(+)CXCR3(+) CAR T cells in infusion products is associated with durable remission in relapsed or refractory diffuse large B-cell lymphoma.

Bartolini R, Trueb L, Daoudlarian D, (…), Pantaleo G, Arber C, Obeid M

Annals of oncology – 2025 Mar 23

Surgical and clinical impacts of mixed reality-guided glioblastoma resection versus standard neuronavigation: improving tumor surgery.

Haemmerli J, Khatchatourov S, Chaboudez E, (…), Migliorini D, Schaller K, Bijlenga P

Frontiers in oncology – 2025 Mar 21